Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10052869HBVENSG00000159110.22protein_codingIFNAR2NoNo3455P48551
Q9BUA0
TVIS30015953HIVENSG00000159110.22protein_codingIFNAR2NoNo3455P48551
Q9BUA0
TVIS30010733HIVENSG00000159110.22protein_codingIFNAR2NoNo3455P48551
Q9BUA0
TVIS30008061HIVENSG00000159110.22protein_codingIFNAR2NoNo3455P48551
Q9BUA0
TVIS30008062HIVENSG00000159110.22protein_codingIFNAR2NoNo3455P48551
Q9BUA0
TVIS30074702HIVENSG00000159110.22protein_codingIFNAR2NoNo3455P48551
Q9BUA0
TVIS30054550HIVENSG00000159110.22protein_codingIFNAR2NoNo3455P48551
Q9BUA0
TVIS30054551HIVENSG00000159110.22protein_codingIFNAR2NoNo3455P48551
Q9BUA0
TVIS30054552HIVENSG00000159110.22protein_codingIFNAR2NoNo3455P48551
Q9BUA0
TVIS44011233HTLV-1ENSG00000159110.22protein_codingIFNAR2NoNo3455P48551
Q9BUA0
TCGA Plot Options
Drug Information
GeneIFNAR2
DrugBank IDDB00069
Drug NameInterferon alfacon-1
Target IDBE0000385
UniProt IDP48551
Regulation Typebinder
PubMed IDs8836913; 12528473; 11752352
CitationsBlatt LM, Davis JM, Klein SB, Taylor MW: The biologic activity and molecular characterization of a novel synthetic interferon-alpha species, consensus interferon. J Interferon Cytokine Res. 1996 Jul;16(7):489-99.@@Yasuda S, Miyata K: [Interferon alfacon-1 (Advaferon): a novel synthetic interferon for the treatment of hepatitis C, its pharmacological and clinical profile]. Nihon Yakurigaku Zasshi. 2002 Dec;120(6):421-6.@@Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.
GroupsApproved; Investigational
Direct ClassificationPeptides
SMILES
Pathways
PharmGKBPA164749376
ChEMBLCHEMBL1201557